{"id":"https://openalex.org/W3022326295","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1832.1832","title":"A Systematic Review and Network Meta-Analysis of Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant","display_name":"A Systematic Review and Network Meta-Analysis of Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplant","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W3022326295","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1832.1832","mag":"3022326295"},"language":"en","primary_location":{"id":"mag:3022326295","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1832.1832","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/1832/79637/A-Systematic-Review-and-Network-Meta-Analysis-of","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"review","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018540296","display_name":"Susanne Schmitz","orcid":"https://orcid.org/0000-0003-4753-1709","observed_orcids":["https://orcid.org/0000-0003-4753-1709"]},"institutions":[{"id":"https://openalex.org/I4210101141","display_name":"Luxembourg Institute of Health","ror":"https://ror.org/012m8gv78","country_code":"LU","type":"nonprofit","lineage":["https://openalex.org/I4210101141"]}],"countries":["LU"],"is_corresponding":false,"raw_author_name":"Susanne Schmitz","raw_affiliation_strings":["Luxembourg Institute of Health, Strassen, Luxembourg"],"raw_orcid":"https://orcid.org/0000-0003-4753-1709","affiliations":[{"raw_affiliation_string":"Luxembourg Institute of Health, Strassen, Luxembourg","institution_ids":["https://openalex.org/I4210101141"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063849382","display_name":"Vanessa Buchanan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vanessa Buchanan","raw_affiliation_strings":["Cogentia Healthcare Consulting, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cogentia Healthcare Consulting, Cambridge, United Kingdom","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055428530","display_name":"Joy Leahy","orcid":"https://orcid.org/0000-0002-6567-9099","observed_orcids":["https://orcid.org/0000-0002-6567-9099"]},"institutions":[{"id":"https://openalex.org/I205274468","display_name":"Trinity College Dublin","ror":"https://ror.org/02tyrky19","country_code":"IE","type":"education","lineage":["https://openalex.org/I205274468"]}],"countries":["IE"],"is_corresponding":false,"raw_author_name":"Joy Leahy","raw_affiliation_strings":["Trinity Coll., Univ. of Dublin, Dublin, Ireland"],"raw_orcid":"https://orcid.org/0000-0002-6567-9099","affiliations":[{"raw_affiliation_string":"Trinity Coll., Univ. of Dublin, Dublin, Ireland","institution_ids":["https://openalex.org/I205274468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090001740","display_name":"Sujith Dhanasiri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sujith Dhanasiri","raw_affiliation_strings":["Celgene International, Boudry, Switzerland;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Celgene International, Boudry, Switzerland;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072977279","display_name":"Charlotte Pawlyn","orcid":"https://orcid.org/0000-0002-7190-0028","observed_orcids":["https://orcid.org/0000-0002-7190-0028"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Pawlyn","raw_affiliation_strings":["The Institute of Cancer Research, Sutton, United Kingdom;"],"raw_orcid":"https://orcid.org/0000-0002-7190-0028","affiliations":[{"raw_affiliation_string":"The Institute of Cancer Research, Sutton, United Kingdom;","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103242404","display_name":"John Ashcroft","orcid":"https://orcid.org/0000-0002-9252-4180","observed_orcids":["https://orcid.org/0000-0002-9252-4180"]},"institutions":[{"id":"https://openalex.org/I4210160067","display_name":"Mid Yorkshire Hospitals NHS Trust","ror":"https://ror.org/05g23q746","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210160067"]},{"id":"https://openalex.org/I4210160796","display_name":"Pinderfields Hospital","ror":"https://ror.org/04tbm0m52","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210160067","https://openalex.org/I4210160796"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"John Ashcroft","raw_affiliation_strings":["Mid-Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield, England"],"raw_orcid":"https://orcid.org/0000-0002-9252-4180","affiliations":[{"raw_affiliation_string":"Mid-Yorkshire Hospitals NHS Trust, Pinderfields Hospital, Wakefield, England","institution_ids":["https://openalex.org/I4210160067","https://openalex.org/I4210160796"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0457,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.07725322,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"130","issue":null,"first_page":"1832","last_page":"1832"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/newly-diagnosed-multiple-myeloma","display_name":"newly diagnosed multiple myeloma","score":0.9330000281333923},{"id":"https://openalex.org/keywords/maintenance-therapy","display_name":"maintenance therapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9739999771118164},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.9480000138282776},{"id":"https://openalex.org/keywords/thalidomide","display_name":"thalidomide","score":1.0},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9369999766349792},{"id":"https://openalex.org/keywords/event-free-survival","display_name":"event-free survival","score":0.9039999842643738},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9929999709129333},{"id":"https://openalex.org/keywords/treatment-efficacy-comparison","display_name":"treatment efficacy comparison","score":0.5569999814033508},{"id":"https://openalex.org/keywords/transplant-ineligible-patients","display_name":"transplant-ineligible patients","score":0.6759999990463257},{"id":"https://openalex.org/keywords/crossover-adjustment","display_name":"crossover adjustment","score":0.38100001215934753},{"id":"https://openalex.org/keywords/risk-of-bias","display_name":"risk of bias","score":0.5249999761581421},{"id":"https://openalex.org/keywords/treatment-related-adverse-events","display_name":"treatment-related adverse events","score":0.3269999921321869},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.4749999940395355}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7845227122306824},{"id":"https://openalex.org/C2776063141","wikidata":"https://www.wikidata.org/wiki/Q425681","display_name":"Lenalidomide","level":3,"score":0.6586317420005798},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.6222169995307922},{"id":"https://openalex.org/C2779609412","wikidata":"https://www.wikidata.org/wiki/Q203174","display_name":"Thalidomide","level":3,"score":0.5818679332733154},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5790908336639404},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.5737579464912415},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.539289116859436},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5000813007354736},{"id":"https://openalex.org/C2781098529","wikidata":"https://www.wikidata.org/wiki/Q20948663","display_name":"Ixazomib","level":5,"score":0.47751584649086},{"id":"https://openalex.org/C2780739268","wikidata":"https://www.wikidata.org/wiki/Q2112244","display_name":"Progression-free survival","level":3,"score":0.4660101532936096},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.44974473118782043},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.44536322355270386},{"id":"https://openalex.org/C2778283404","wikidata":"https://www.wikidata.org/wiki/Q6736822","display_name":"Maintenance therapy","level":3,"score":0.41118061542510986},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3433983027935028},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.19518253207206726},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.16728240251541138},{"id":"https://openalex.org/C2780108899","wikidata":"https://www.wikidata.org/wiki/Q15366934","display_name":"Carfilzomib","level":4,"score":0.10625797510147095}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3022326295","doi":"https://doi.org/10.1182/blood.v130.suppl_1.1832.1832","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/1832/79637/A-Systematic-Review-and-Network-Meta-Analysis-of","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4310109030","https://openalex.org/W3093393910","https://openalex.org/W2737964630","https://openalex.org/W3120452471","https://openalex.org/W3029757488","https://openalex.org/W2768446463","https://openalex.org/W4407176323","https://openalex.org/W7213454225","https://openalex.org/W3097243364","https://openalex.org/W4389233504"],"abstract_inverted_index":{"Abstract":[0],"BACKGROUND":[3],"The":[5,36,91,262,307,478,504,571],"European":[6,43,222],"Society":[7],"for":[8,23,48,81,139,169,268,316,356,413,419,428,439,480,540,600],"Medical":[9],"Oncology":[10],"(ESMO)":[11],"and":[12,39,42,61,74,88,105,125,209,239,324,458,471,526,579,594],"the":[13,57,62,99,126,146,170,205,215,245,254,265,362,378,393,448,508,551],"National":[14],"Comprehensive":[15],"Cancer":[16],"Network":[17],"(NCCN)":[18],"guidelines":[19],"recommend":[20],"maintenance":[21,52,82,109,149,188,258,408,438,482,565,578,588],"treatment":[22,53,83,110,150,259,381,396,409,485,566,589],"patients":[24,112,152,160,339,414,568],"with":[25,113,153,277,298,327,337,340,375,415,422,491,516,569],"newly":[26],"diagnosed":[27],"multiple":[28],"myeloma":[29],"(NDMM)":[30],"post-autologous":[31],"stem":[32],"cell":[33],"transplant":[34],"(ASCT).":[35],"US":[37],"Food":[38],"Drug":[40],"Administration":[41],"Medicines":[44],"Agency":[45],"granted":[46],"approval":[47],"lenalidomide":[49],"(LEN)":[50],"as":[51,84,108,164,166,221,273,280,563,587],"in":[54,86,111,131,151,204,361,486,507,567,590],"2017.":[55],"Given":[56],"high":[58],"unmet":[59],"need":[60],"previous":[63],"absence":[64,206],"of":[65,93,102,123,148,187,191,207,248,257,330,406,447,467,473,493,543,557,574],"a":[66,494],"licensed":[67],"treatment,":[68],"other":[69,423,459,560,580],"agents,":[70],"including":[71,323,461],"bortezomib":[72],"(BORT)":[73],"thalidomide":[75],"(THAL),":[76],"have":[77,178],"also":[78,162],"been":[79,305],"studied":[80],"discussed":[85],"ESMO":[87],"NCCN":[89],"guidelines.":[90],"objective":[92],"this":[94,442,487,527,591],"analysis":[95,449,528],"was":[96,250,392,444],"to":[97,177,185,201,244,252,291,372,432,513,553],"investigate":[98],"relative":[100,255,266,555],"effectiveness":[101],"LEN,":[103,346,420],"THAL,":[104,350],"BORT":[106],"monotherapies":[107],"NDMM":[114,154,342],"post-ASCT.":[115,155],"METHODS":[117],"Medline,":[119],"Embase,":[120],"Cochrane,":[121],"Web":[122],"Science,":[124],"grey":[127],"literature":[128],"were":[129,161,173,193,226,320,343,359,425],"searched":[130],"September":[132],"2016":[133],"(with":[134],"no":[135,352,373,437,484,577],"start":[136],"date":[137],"limit)":[138],"randomised":[140],"controlled":[141],"trials":[142,326,457,525],"(RCTs)":[143],"that":[144,157],"examined":[145],"effect":[147,256],"Trials":[156],"recruited":[158],"transplant-ineligible":[159],"included,":[163,309],"long":[165],"outcomes":[167,314,371,533,573],"data":[168,297,522],"transplant-eligible":[171],"subgroups":[172],"available.":[174,229],"Patients":[175],"had":[176,303,369],"achieved":[179],"stable":[180],"disease":[181],"following":[182,476],"ASCT":[183],"prior":[184,237],"initiation":[186],"treatment.":[189],"Outcomes":[190,213],"interest":[192],"progression-free":[194],"survival":[195,198,211,288,295],"(PFS),":[196],"event-free":[197],"or":[199],"time":[200,454,536],"progression":[202],"(used":[203],"PFS),":[208],"overall":[210],"(OS).":[212],"from":[214,523,534],"most":[216,379,394],"mature":[217],"published":[218],"data,":[219],"such":[220],"Public":[223],"Assessment":[224],"Reports,":[225],"incorporated":[227],"when":[228,310],"A":[230],"Bayesian":[231],"network":[232],"meta-analysis":[233,496],"(NMA)":[234],"using":[235,313],"non-informative":[236],"distributions":[238],"assuming":[240,285],"fixed":[241],"effects":[242],"(due":[243],"limited":[246],"number":[247],"trials)":[249],"fitted":[251],"evaluate":[253],"on":[260,531],"outcomes.":[261],"model":[263,289],"estimated":[264,360],"efficacy":[267,556],"each":[269,357],"pairwise":[270],"comparison,":[271],"measured":[272],"hazard":[274],"ratios":[275],"(HRs),":[276],"uncertainty":[278],"captured":[279],"95%":[281],"credible":[282],"intervals":[283],"(CrIs),":[284],"an":[286,596],"exponential":[287],"applied":[290],"median":[292,302],"PFS/OS":[293],"and/or":[294,604],"rate":[296],"patient":[299,463,592],"numbers":[300],"if":[301],"not":[304],"reached.":[306],"NMA":[308,488,549],"available,":[311],"analyses":[312,319],"adjusted":[315],"crossover.":[317],"Sensitivity":[318],"carried":[321],"out,":[322],"excluding":[325],"significant":[328],"risk":[329],"bias.":[331],"RESULTS":[333],"Seven":[335],"RCTs":[336],"3113":[338],"post-ASCT":[341,416,564],"included":[344],"(1056":[345],"302":[347],"BORT,":[348],"528":[349],"1227":[351],"treatment/placebo).":[353],"Pairwise":[354],"comparisons":[355],"outcome":[358],"analysis.":[363],"For":[364,389],"PFS,":[365],"all":[366],"active":[367,407,561,581],"treatments":[368],"superior":[370,572],"maintenance/placebo,":[374],"LEN":[376,391,481,558,575],"being":[377,529],"effective":[380,395,435],"(HR,":[382,397],"0.47":[383],"[95%":[384,399],"CrI,":[385,400],"0.42-0.54])":[386],"(Figure":[387,402],"1a).":[388],"OS,":[390,440],"0.78":[398],"0.66-0.92])":[401],"1b).":[403],"Use":[405],"consistently":[410],"improved":[411],"PFS":[412],"NDMM.":[417,570],"Except":[418],"results":[421,479],"agents":[424],"less":[426,434],"consistent":[427,490],"OS.":[429],"THAL":[430],"appeared":[431],"be":[433,511],"than":[436],"although":[441],"finding":[443],"non-significant.":[445],"Limitations":[446],"include":[450],"different":[451,462,468,474,514,535],"OS":[452],"follow-up":[453],"points":[455,537],"across":[456],"heterogeneity,":[460],"baseline":[464],"characteristics,":[465],"use":[466,472,586],"induction":[469],"regimens,":[470],"regimens":[475],"progression.":[477],"vs":[483,559],"are":[489],"those":[492],"recent":[495],"(McCarthy":[497],"et":[498,518],"al.":[499],"J":[500],"Clin":[501],"Oncol":[502],"2017).":[503],"small":[505],"differences":[506],"estimates":[509],"can":[510],"attributed":[512],"methodology,":[515],"McCarthy":[517],"al":[519],"analysing":[520],"patient-level":[521],"3":[524],"based":[530],"aggregate":[532],"but":[538],"providing":[539],"greater":[541],"consideration":[542],"uncertainty.":[544],"CONCLUSION":[546],"This":[548],"is":[550],"first":[552],"assess":[554],"therapies":[562,582],"over":[576],"further":[583],"support":[584],"its":[585],"population":[593],"provides":[595],"important":[597],"evidence":[598],"base":[599],"health":[601],"technology":[602],"assessment":[603],"clinical":[605],"decision-making.":[606],"Download":[616,619,629,632],":":[617,630],"high-res":[620],"image":[621,634],"(87KB)":[622],"full-size":[633],"Disclosures":[646],"Schmitz:":[648],"Celgene:":[649,652,670,676],"Consultancy.":[650,653],"Buchanan:":[651],"Dhanasiri:":[654],"Celgene":[655],"Corporation:":[656],"Employment,":[657],"Equity":[658],"Ownership.":[659],"Pawlyn:":[660],"Takeda:":[661,690],"Honoraria,":[662,671,678,682,687,692],"Other:":[663,667,672],"Travel":[664,668,673],"support;":[665,669],"Janssen:":[666,685],"support.":[674],"Ashcroft:":[675],"Consultancy,":[677,686,691],"Speakers":[679,683,688,693],"Bureau;":[680,684,689],"Amgen:":[681],"Bureau.":[694]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2020-05-13T00:00:00"}